0001562180-21-004412.txt : 20210621 0001562180-21-004412.hdr.sgml : 20210621 20210621201855 ACCESSION NUMBER: 0001562180-21-004412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210617 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chard Daniel R CENTRAL INDEX KEY: 0001289557 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31573 FILM NUMBER: 211032685 MAIL ADDRESS: STREET 1: NU SKIN ENTERPRISES, INC. STREET 2: 75 WEST CENTER STREET CITY: PROVO STATE: UT ZIP: 84601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIFAST INC CENTRAL INDEX KEY: 0000910329 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090] IRS NUMBER: 133714405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 BUSINESS PHONE: 7327640619 MAIL ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHRITE INC DATE OF NAME CHANGE: 19951120 FORMER COMPANY: FORMER CONFORMED NAME: XX DATE OF NAME CHANGE: 19950619 FORMER COMPANY: FORMER CONFORMED NAME: 00 DATE OF NAME CHANGE: 19950619 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-06-17 false 0000910329 MEDIFAST INC MED 0001289557 Chard Daniel R C/O MEDIFAST, INC. 100 INTERNATIONAL DRIVE, 18TH FLOOR BALTIMORE MD 21202 true true false false Chairman & CEO Common Stock 2021-06-17 4 S false 600.00 259.3225 D 112091.00 D Common Stock 2021-06-17 4 S false 1000.00 260.3738 D 111091.00 D Common Stock 2021-06-17 4 S false 1000.00 261.456 D 110091.00 D Common Stock 2021-06-17 4 S false 600.00 262.54 D 109491.00 D Common Stock 2021-06-17 4 S false 863.00 263.3124 D 108628.00 D Common Stock 2021-06-17 4 S false 213.00 264.3453 D 108415.00 D Common Stock 2021-06-17 4 S false 287.00 265.2889 D 108128.00 D Common Stock 2021-06-17 4 S false 802.00 267.0011 D 107326.00 D Common Stock 2021-06-17 4 S false 502.00 268.0049 D 106824.00 D Common Stock 2021-06-17 4 S false 298.00 269.1175 D 106526.00 D Common Stock 2021-06-17 4 S false 200.00 270.095 D 106326.00 D The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021 This transaction was executed in multiple trades at prices ranging from $267.73 USD to $268.71 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $268.87 USD to $269.61 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $270.09 USD to $270.10 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $258.74 USD to $259.66 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $259.83 USD to $260.82 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $260.94 USD to $261.92 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $262.00 USD to $262.96 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $263.00 USD to $263.48 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $264.10 USD to $265.07 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $265.10 USD to $265.79 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $266.66 USD to $267.54 USD; the price reported above reflects the weighted average sale price. /s/ Jason L. Groves, attorney-in-fact 2021-06-21